Home › Funds › Cormorant Asset Management, LP › IRD
Cormorant Asset Management, LP position in IRD
OPUS GENETICS INC · Health Care
Cormorant Asset Management, LP reported holding 5,500,000 shares of IRD (OPUS GENETICS INC) in its Q3 2026 13F filing — a position valued at US$26.6M, representing 1.90% of its reported portfolio and ranking #18 among its reported holdings. Cormorant Asset Management, LP first reported this position in Q3 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Cormorant Asset Management, LP's IRD position evolved
Cormorant Asset Management, LP first disclosed a stake in IRD in Q3 2026 at 5,500,000 shares (US$26.6M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 5.50M | $26.62M | New |
About IRD and 13F data
IRD (OPUS GENETICS INC) is a Health Care company. 68 other funds we track also report a position in IRD — the largest reported positions include BIOS Capital Management, LP (US$17.83B), PERCEPTIVE ADVISORS LLC (US$43.6M), Caligan Partners LP (US$28.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IRD
- BIOS Capital Management, LP 3.68M sh · $17.83B · Q3 2026
- PERCEPTIVE ADVISORS LLC 9.00M sh · $43.56M · Q3 2026
- Caligan Partners LP 5.96M sh · $28.85M · Q3 2026
- Nantahala Capital Management, LLC 4.57M sh · $22.12M · Q3 2026
- Boxer Capital Management, LLC 4.53M sh · $21.94M · Q3 2026
- Trails Edge Capital Partners, LP 2.41M sh · $11.67M · Q3 2026
- Blue Owl Capital Holdings LP 969.61K sh · $4.69M · Q3 2026
- Opaleye Management Inc. 1.12M sh · $4.62M · Q2 2026
- GREAT POINT PARTNERS LLC 776.88K sh · $3.76M · Q3 2026
- ACUTA CAPITAL PARTNERS, LLC 514.11K sh · $2.49M · Q3 2026
- Propel Bio Management, LLC 270.04K sh · $1.31M · Q3 2026
- Stonepine Capital Management, LLC 98.15K sh · $475.03K · Q3 2026
More on Cormorant Asset Management, LP
FAQ
How long has Cormorant Asset Management, LP held IRD?
Cormorant Asset Management, LP has disclosed IRD holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Cormorant Asset Management, LP's current position in IRD?
As of Q3 2026, Cormorant Asset Management, LP holds 5.50M shares of IRD (OPUS GENETICS INC), valued at $26.62M, representing 1.90% of its reported portfolio and ranking #18.
Has Cormorant Asset Management, LP been buying or selling IRD?
In the latest 13F filing (Q3 2026), Cormorant Asset Management, LP newly opened its position in IRD.
Which other funds hold IRD?
Other major institutional holders of IRD include BIOS Capital Management, LP, PERCEPTIVE ADVISORS LLC, Caligan Partners LP, among 68 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.